Brent A. Orr

10.2k citations

125 papers · 3.1k indexed · h-index 34

Impact in

Genetics top 0.5%
- Glioma Diagnosis and Treatment
Cancer Research top 5%
- MicroRNA in disease regulation

Papers in

Genetics 64
- Glioma Diagnosis and Treatment 64
Neurology 28
- Neuroblastoma Research and Treatments 15

Co-authors: Charles G. Eberhart Amar Gajjar Giles Robinson Fausto J. Rodríguez Yazmín Odia Sariah J. Allen David M. Kranz Jarek Maciaczyk
Journals: Neuro-Oncology (18 papers)Brain Pathology (8 papers)Acta Neuropathologica (8 papers)Neuro-Oncology Advances (6 papers)Journal of Neurosurgery Pediatrics (4 papers)
Partner nations: United States Germany Australia

In The Last Decade

Brent A. Orr

115 papers receiving 3.1k citations

Peers

Countries citing papers authored by Brent A. Orr

Since Specialization

Citations

This map shows the geographic impact of Brent A. Orr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent A. Orr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent A. Orr more than expected).

Fields of papers citing papers by Brent A. Orr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent A. Orr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent A. Orr. The network helps show where Brent A. Orr may publish in the future.

Co-authors

The 25 scholars most cited alongside Brent A. Orr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brent A. Orr Line = papers co-authored together Brent A. Orr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics Neuro-Oncology Advances ·Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R. Gilbert, Cynthia Hawkins, Juergen Hench, Thomas S. Jacques, David Jones, David N. Louis, Sabine Mueller, Brent A. Orr, MacLean P. Nasrallah, Stefan M. Pfister, Felix Sahm, Matija Snuderl, David A. Solomon, Pascale Varlet, Pieter Wesseling	2025	9
2	cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors Brain Pathology ·Pieter Wesseling, David Capper, Guido Reifenberger, Chitra Sarkar, Cynthia Hawkins, Arie Perry, B. K. Kleinschmidt‐DeMasters, Takashi Komori, Werner Paulus, Vani Santosh, Martin J. van den Bent, Michael Weller, Stefan M. Pfister, Uri Tabori, Dominique Figarella‐Branger, Brent A. Orr, David N. Louis	2025	1
3	Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery Cancer Management and Research ·Allison F. O’Neill, Raul C. Ribeiro, Emília M. Pinto, Michael R. Clay, Gerard P. Zambetti, Brent A. Orr, Christopher B. Weldon, Carlos Rodríguez‐Galindo	2024	2
4	Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors npj Precision Oncology ·Quynh T. Tran, Alex Breuer, Tong Lin, Ruth Tatevossian, Sariah J. Allen, Michael R. Clay, Larissa V. Furtado, Jinan Chen, Dale J. Hedges, Tylman Michael, Giles Robinson, Paul A. Northcott, Amar Gajjar, Elizabeth M. Azzato, Sheila Shurtleff, David W. Ellison, Stanley Pounds, Brent A. Orr	2024	4
5	ETMR-31. A UNIQUE CASE OF CNS DIFFUSE, NON-SYSTEMIC ALK+ HISTIOCYTOSIS IN A PEDIATRIC PATIENT Neuro-Oncology ·Samantha J DeMarsh, Brent A. Orr, Nicholas Willard, Nathan Dahl	2024	0
6	Concurrent peripheral T-cell lymphoma and T-cell lymphoblastic leukemia/lymphoma with identical <i>STIL</i>::<i>TAL1</i> fusion events Haematologica ·Mahsa Khanlari, Wei Wang, Yen‐Chun Liu, Lu Wang, Jeffrey E. Rubnitz, Stephanie B. Dixon, Brent A. Orr, Obianuju Mercy Anelo, Zhongshan Cheng, Vidya Balagopal, Jeffery M. Klco	2023	0
7	DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts Acta Neuropathologica ·Quynh T. Tran, Santhosh A. Upadhyaya, Catherine A. Billups, Arzu Onar‐Thomas, Md Zahangir Alom, Steven S. Carey, Giles Robinson, David W. Ellison, Amar Gajjar, Brent A. Orr	2023	4
8	Primary cilia control translation and the cell cycle in medulloblastoma Genes & Development ·Yong Ha Youn, Shirui Hou, Chang‐Chih Wu, Daisuke Kawauchi, Brent A. Orr, Giles Robinson, David Finkelstein, Makoto M. Taketo, Richard J. Gilbertson, Martine F. Roussel, Young-Goo Han	2022	23
9	The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma Developmental Cell ·Anand G. Patel, Xiang Chen, Xin Huang, Michael R. Clay, Natalia L. Komarova, Matthew J. Krasin, Alberto S. Pappo, Heather Tillman, Brent A. Orr, Justina McEvoy, Brittney Gordon, Kaley Blankenship, Colleen Reilly, Xin Zhou, Jacqueline L. Norrie, Åsa Karlström, Jiyang Yu, Dominik Wodarz, Elizabeth Stewart, Michael A. Dyer	2022	37
10	An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling Cancer Research ·Juwina Wijaya, BaoHan T. Vo, Jingjing Liu, Beisi Xu, Gang Wu, Yao Wang, Junmin Peng, Jin Zhang, Laura J. Janke, Brent A. Orr, Jiyang Yu, Martine F. Roussel, John D. Schuetz	2020	7
11	Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine Clinical Cancer Research ·Sabrina Wang, Brad Poore, Jesse Alt, Antoinette Price, Sariah J. Allen, Allison R. Hanaford, Harpreet Kaur, Brent A. Orr, Barbara S. Slusher, Charles G. Eberhart, Eric H. Raabe, Jeffrey Rubens	2019	23
12	H3 K27M Mutations in Thalamic Pilocytic Astrocytomas with Anaplasia World Neurosurgery ·Tarek Y. El Ahmadieh, Aaron Plitt, Benjamin Kafka, Salah G. Aoun, Jack Raisanen, Brent A. Orr, Edward Pan, Zabi Wardak, Lucien Nedzi, Toral Patel	2019	7
13	Mouse medulloblastoma driven by CRISPR activation of cellular Myc Scientific Reports ·BaoHan T. Vo, Jin Ah Kwon, Chunliang Li, David Finkelstein, Beisi Xu, Brent A. Orr, Charles J. Sherr, Martine F. Roussel	2018	16
14	NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors Acta Neuropathologica Communications ·Maria‐Magdalena Georgescu, Bret C. Mobley, Brent A. Orr, Ping Shang, Norman L. Lehman, Xiaoping Zhu, Thomas J. O’Neill, Veena Rajaram, Kimmo J. Hatanpaa, Charles F. Timmons, Jack Raisanen	2016	9
15	Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy Neuro-Oncology ·Karen Tsui, Amar Gajjar, Chenghong Li, Deo Kumar Srivastava, Alberto Broniscer, Cynthia Wetmore, Larry E. Kun, Thomas E. Merchant, David W. Ellison, Brent A. Orr, Frederick A. Boop, Paul Klimo, Jordan D. Ross, Leslie L. Robison, Gregory T. Armstrong	2014	35
16	Enophthalmos and Choroidal Atrophy after Intraophthalmic Artery Chemotherapy for Retinoblastoma Ophthalmology ·Brian C. Tse, Sue C. Kaste, Rachel C. Brennan, Brent A. Orr, Matthew W. Wilson	2014	7
17	Prolonged Inhibition of Glioblastoma Xenograft Initiation and Clonogenic Growth following In Vivo Notch Blockade Clinical Cancer Research ·Qian Chu, Brent A. Orr, Samantha Semenkow, Eli E. Bar, Charles G. Eberhart	2013	39
18	Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas Molecular Cancer Research ·Gilson S. Baía, Otávia L. Caballero, Brent A. Orr, Anita Lal, Janelle S.Y. Ho, Cynthia Cowdrey, Tarık Tihan, Christian Mawrin, Gregory J. Riggins	2012	53
19	Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor Gene Therapy ·K-W Peng, Patrick Höller, Brent A. Orr, David M. Kranz, Stephen J. Russell	2004	30
20	IL-12 Treatment of Endogenously Arising Murine Brain Tumors The Journal of Immunology ·Edward J. Roy, Ute Gawlick, Brent A. Orr, Laurie A. Rund, Andrew Webb, David M. Kranz	2000	30

About Brent A. Orr

Brent A. Orr is a scholar working on Genetics, Neurology, Cancer Research, Ophthalmology and Molecular Biology, having authored 125 papers that have together received 3.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (64 papers), Chromatin Remodeling and Cancer (24 papers), Epigenetics and DNA Methylation (16 papers), Neuroblastoma Research and Treatments (15 papers), Cancer Mechanisms and Therapy (13 papers), Meningioma and schwannoma management (12 papers), Hedgehog Signaling Pathway Studies (12 papers) and Sarcoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Genetics (1.2k citations), Cancer Research (640 citations), Neurology (537 citations), Molecular Biology (1.8k citations) and Oncology (498 citations). Brent A. Orr has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Charles G. Eberhart, Amar Gajjar, Giles Robinson, Fausto J. Rodríguez, Yazmín Odia, Sariah J. Allen, David M. Kranz, Jarek Maciaczyk, Ulf D. Kahlert and Michael C. Haffner. Their work appears in journals such as Neuro-Oncology, Brain Pathology, Acta Neuropathologica, Neuro-Oncology Advances and Journal of Neurosurgery Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact